MERCK SELLS FEDERALLY FINANCED COVID PILL TO U.S. FOR 40 TIMES WHAT IT COSTS TO MAKE

The Intercept

By Sharon Lerner – October 5 2021, 1:22 p.m.

A FIVE-DAY COURSE of molnupiravir, the new medicine being hailed as a “huge advance” in the treatment of Covid-19, costs $17.74 to produce, according to a report issued last week by drug pricing experts at the Harvard School of Public Health and King’s College Hospital in London. Merck is charging the U.S. government $712 for the same amount of medicine, or 40 times the price.

Read more…